Anti-Human CD221 Recombinant Antibody(Teprotumumab)

Product Information

Catalog Number	YR1228
Product Name	Anti-Human CD221 Recombinant Antibody(Teprotumumab)
Molecular Name	Teprotumumab
Alias	Anti-CD221 Recombinant Antibody, Research Grade Teprotumumab
CAS Number	1036734-93-6
Molecular Weight	148 kDa
Target	CD221[Homo sapiens]
Isotype	IgG1
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Teprotumumab, sold under the brand name Tepezza, is a medication used to treat adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to bulge outwards.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price